Welcome to MyStrategist, the digital home for Market Pathways.

Market Pathways covers the people, challenges, and opportunities impacting the global medtech regulatory, reimbursement, and policy communities. We invite you to explore our coverage. Think Strategically. Subscribe Today

Browse   Latest Issue

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review


Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review


Regulatory & Reimbursement

CMS Ponders the Path Ahead for AI Payments

The Medicare agency acknowledges its methodologies to calculate payments are not well-suited to account for the costs and efficiencies of AI software. In its 2022 Physician Fee Schedule proposal out this week, CMS is seeking detailed input to help reform its systems while trying to come up with temporary solutions to provide sufficient reimbursement in the short term.

Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.

Subscribe Now   Learn More
More From Market Pathways:

‘Pathways’ Picks’ August 27: The News this Week

Welcome to the August 27 edition of ‘Pathways’ Picks,’ MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week: UK leadership changes, spotlight on single-use device reprocessing, streamlining in Hong Kong, and more.

Read Article